Just Diagnosed With AFib? Your First 90 Days, Explained
Atrial fibrillation (AFib) management has three goals: control your heart rate, restore or maintain normal rhythm when appropriate, and prevent stroke with anticoagulation when indicated. The stroke prevention decision is made first, based on your CHA2DS2-VASc score, and is largely independent of whether you have symptoms. Most newly diagnosed patients receive medications within the first 30 days, and major decisions like cardioversion or ablation are typically considered between days 30 and 90.
The diagnosis arrives fast. An irregular pulse at a check-up, an unexpected reading on a smartwatch, an ER visit for palpitations. Within an hour you have heard the words atrial fibrillation, and the next 90 days are when most of the important decisions happen.
What AFib actually is (and what it is not)
Atrial fibrillation is a heart rhythm disorder in which the top two chambers of the heart (the atria) quiver instead of beating in a coordinated rhythm. The result is an irregularly irregular pulse, sometimes fast (over 100 beats per minute), sometimes within normal range.
Symptoms vary widely. Some patients feel palpitations, breathlessness, lightheadedness, or fatigue. Others have no symptoms and only discover AFib through a routine EKG or wearable device.
AFib is not a heart attack. It is not immediately life-threatening in most cases. But it does raise stroke risk significantly, and it does need a thoughtful treatment plan. Both of those are what the next 90 days are about.
Why your stroke risk matters first
The single most important early decision in AFib management is whether you need a blood thinner to prevent a stroke. This decision comes first, before rate or rhythm strategy.
When the atria fibrillate instead of contracting, blood can pool in a small pouch called the left atrial appendage. Pooled blood is prone to clotting. If a clot forms there and breaks loose, it can travel to the brain and cause a stroke. Roughly 1 in 5 strokes in the United States is attributed to AFib.
The right anticoagulant medication reduces this risk substantially. The decision about whether to start one is based on an assessment of your individual risk, not on whether you have symptoms.
Understanding your CHA2DS2-VASc score in plain English
Your cardiologist will calculate a score called CHA2DS2-VASc. It looks like a complicated acronym, but it is a simple checklist of stroke risk factors. Each box adds points:
- C: Congestive heart failure (1 point)
- H: Hypertension (1 point)
- A2: Age 75 or older (2 points)
- D: Diabetes (1 point)
- S2: Prior stroke or TIA (2 points)
- V: Vascular disease, prior heart attack, or PAD (1 point)
- A: Age 65 to 74 (1 point)
- Sc: Sex category female (1 point)
Score interpretation in broad strokes: 0 to 1 in men or 1 to 2 in women suggests lower risk where benefit of anticoagulation may not outweigh bleeding risk. Higher scores indicate the protective benefit of anticoagulation typically outweighs bleeding risk and medication is recommended. Your cardiologist weighs the score against your bleeding risk, kidney function, other medications, and your preferences.
The three treatment goals: rate, rhythm, stroke prevention
AFib management runs on three tracks, and most patients address all three at the same time:
- Rate control keeps the ventricular response from running too fast even when the atria are fibrillating. Common medications include metoprolol, carvedilol, or diltiazem.
- Rhythm control tries to restore and maintain a normal sinus rhythm using antiarrhythmic medications or procedures like cardioversion and catheter ablation.
- Stroke prevention with anticoagulation is the foundational decision, addressed regardless of which rate or rhythm strategy is chosen.
For some patients, rate control alone is enough and they live well with well-controlled AFib. For others, restoring sinus rhythm relieves symptoms and improves quality of life dramatically. The right strategy is patient-specific.
Medications you might be prescribed
The AFib medication list is comprehensive. Here is the layout:
- Anticoagulants (blood thinners): apixaban, rivaroxaban, dabigatran, edoxaban, and warfarin. The newer agents (DOACs) have become standard for most patients because they require less monitoring than warfarin.
- Rate-control medications: beta blockers (metoprolol, atenolol, carvedilol) and certain calcium channel blockers (diltiazem, verapamil). Digoxin is used less commonly now.
- Rhythm-control medications (antiarrhythmics): flecainide, propafenone, sotalol, dofetilide, and amiodarone. These require careful selection based on your other health conditions and are typically managed by a cardiologist.
When cardioversion is recommended
Cardioversion is a brief, planned procedure where a synchronized electrical shock or specific medication restores normal sinus rhythm. It is performed under sedation, takes 15 to 30 minutes, and most patients walk out the same day.
Cardioversion is often considered when AFib has been present for less than a year, when symptoms significantly affect quality of life, or when initial medication management has not restored rhythm. Before cardioversion, your cardiologist will usually want either at least 3 weeks of anticoagulation OR a transesophageal echocardiogram to confirm there is no clot in the atria.
Cardioversion is not a cure. Many patients have AFib recurrence within months. The decision is whether the temporary restoration of normal rhythm is worth it, and whether longer-term rhythm strategies (medications or ablation) make sense afterward.
When ablation is recommended
Catheter ablation is a more definitive rhythm-control procedure. Through small catheters in the leg veins, electrical signals in the atria are mapped, and abnormal triggers (most often around the pulmonary veins) are isolated using radiofrequency or cryotherapy energy. The procedure typically takes 2 to 4 hours and is performed in a specialized lab.
Ablation is generally considered when antiarrhythmic medications have failed or are not well tolerated, when symptoms are significant, and when the patient is otherwise a reasonable candidate. Success rates are generally quite favorable for paroxysmal (intermittent) AFib, with somewhat lower rates for persistent AFib.
Ablation is not for everyone. The decision involves weighing your symptom burden, AFib type, age, other conditions, and treatment goals.
Lifestyle triggers you can control today
Several lifestyle factors trigger or worsen AFib. Some you can address immediately:
- Alcohol: one of the most reliable triggers. Even moderate amounts provoke episodes in susceptible patients.
- Untreated sleep apnea: strongly associated with AFib. Treating sleep apnea improves AFib outcomes significantly.
- Dehydration and electrolyte shifts: trigger episodes. In Houston heat, more common than people realize.
- Thyroid dysfunction, particularly hyperthyroidism. A simple TSH blood test should be part of your initial workup.
- Caffeine: less of a trigger than people assume but can affect some patients.
- Stress and poor sleep: real contributors. Harder to fix, but worth acknowledging.
What to track over the next 90 days
A few simple data points make your next visit dramatically more productive:
- Episode log: when did you feel symptoms, how long did they last, what were you doing, did you take medication or rest
- Heart rate and rhythm: smartwatches and home BP cuffs detect irregular rhythms. The data is useful at appointments.
- Blood pressure: twice a week at home if hypertensive. AFib and hypertension reinforce each other.
- Symptoms beyond palpitations: fatigue, shortness of breath, lightheadedness. These can indicate rate or rhythm control needs adjusting.
- Side effects from new medications: especially bleeding (unusual bruising, blood in stool or urine, prolonged nosebleeds) on anticoagulants.
Red flags that need same-day evaluation
Most AFib episodes can wait for your next office visit, but a few cannot. Call us today or go to the nearest ER if you experience chest pain or pressure (particularly with shortness of breath), sudden weakness or numbness or vision change (signs of stroke), fainting or near-fainting, heart rate that stays above 130 at rest despite your usual medications, or any sign of significant bleeding while on an anticoagulant.
How we manage AFib at HLHV
At HLHV, AFib care happens across our three locations in Conroe, The Woodlands, and Huntsville. Initial evaluation includes a thorough history and exam, EKG, echocardiogram, thyroid and basic labs, and often a Holter monitor or loop recorder to characterize the AFib burden. From there, we coordinate medication selection, cardioversion when indicated, and referrals for ablation when that path is the right one. We see patients from across Conroe, Shenandoah, Spring, Tomball, Magnolia, Huntsville, Walker County, and the surrounding North Houston area.
Frequently Asked Questions
Is AFib dangerous if it does not cause symptoms?
Yes. The stroke risk associated with AFib is largely independent of symptoms. Many patients with silent AFib have meaningful stroke risk and benefit from anticoagulation. This is why your cardiologist calculates a stroke risk score regardless of how you feel.
Can AFib go away on its own?
Some AFib episodes terminate spontaneously, particularly in early or paroxysmal AFib. But AFib tends to become more persistent over time as the atria remodel. Active management generally improves long-term outcomes compared to ignoring it.
Do I have to take a blood thinner forever?
If your stroke risk score indicates anticoagulation is recommended, the medication is typically continued long-term, sometimes indefinitely. Even if rhythm is restored with cardioversion or ablation, anticoagulation often continues based on your risk profile, not just whether you are currently in AFib.
How do I know if my AFib is controlled?
The two key markers are symptoms and heart rate. If your symptoms are manageable, your resting heart rate stays in a reasonable range (typically under 110), and your stroke prevention is in place, your AFib is reasonably controlled.
Can I exercise with AFib?
In most cases yes, and exercise is encouraged. Moderate aerobic exercise improves AFib outcomes. The caveats are to avoid maximal effort that pushes your heart rate to unsafe levels, especially if your rate is not well controlled, and to stay hydrated, especially in Texas summers.
Start your AFib management plan
Same-week consultations at Conroe, The Woodlands, and Huntsville. EKG, echo, and labs on-site. Most insurance accepted.
Schedule Your Consultation